Suchergebnisse - "Pyramidal Cells drug effects"

  1. 1
  2. 2

    Quelle: Mol Psychiatry
    MOLECULAR PSYCHIATRY
    r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
    Universidad Católica San Antonio de Murcia (UCAM)
    Molecular Psychiatry
    Molecular psychiatry.

    Dateibeschreibung: application/pdf

  3. 3
  4. 4
  5. 5

    Autoren: Wei, J Yuen, E Y Liu, W et al.

    Quelle: Molecular Psychiatry. 19:588-598

  6. 6

    Quelle: Singapore Medical Journal. 54:315-320

    Dateibeschreibung: application/pdf

  7. 7

    Quelle: Psychopharmacology. 231:1227-1235

  8. 8
  9. 9

    Quelle: Toxicology and Industrial Health. 27:771-778

  10. 10

    Quelle: Anesthesiology, Vol. 112, No 3 (2010) pp. 546-556
    Anesthesiology

    Dateibeschreibung: application/pdf

  11. 11

    Quelle: Brain Research Bulletin. 77:172-177

  12. 12

    Quelle: Neuroscience, Vol. 156, No 3 (2008) pp. 527-36

    Dateibeschreibung: application/pdf

  13. 13

    Autoren: Gaspard, N Bouschet, T Hourez, R et al.

    Quelle: Nature (London), 455 (7211

    Dateibeschreibung: 1 full-text file(s): application/pdf

  14. 14

    Quelle: Price, C J, Scott, R, Rusakov, D A & Capogna, M 2008, 'GABA(B) receptor modulation of feedforward inhibition through hippocampal neurogliaform cells', The Journal of neuroscience, vol. 28, no. 27, pp. 6974-82. https://doi.org/10.1523/JNEUROSCI.4673-07.2008

  15. 15

    Quelle: Elfant, D, Pál, B Z, Emptage, N & Capogna, M 2008, 'Specific inhibitory synapses shift the balance from feedforward to feedback inhibition of hippocampal CA1 pyramidal cells', The European journal of neuroscience, vol. 27, no. 1, pp. 104-13. https://doi.org/10.1111/j.1460-9568.2007.06001.x

    Dateibeschreibung: application/pdf

  16. 16

    Quelle: The Journal of Pharmacology and Experimental Therapeutics. 318:579-588

  17. 17

    Quelle: Shemer, I, Holmgren, C, Min, R, Fülöp, L, Zilberter, M, Sousa, K M, Farkas, T, Härtig, W, Penke, B, Burnashev, N, Tanila, H, Zilberter, Y & Harkany, T 2006, 'Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors', European Journal of Neuroscience, vol. 23, no. 8, pp. 2035-47. https://doi.org/10.1111/j.1460-9568.2006.04733.x

    Dateibeschreibung: application/pdf

  18. 18

    Autoren: COPE DW HALBSGUTH C KARAYANNIS T et al.

    Quelle: Cope, D W, Halbsguth, C, Karayannis, T, Wulff, P, Ferraguti, F, Hoeger, H, Leppä, E, Linden, A-M, Oberto, A, Ogris, W, Korpi, E R, Sieghart, W, Somogyi, P, Wisden, W & Capogna, M 2005, 'Loss of zolpidem efficacy in the hippocampus of mice with the GABAA receptor gamma2 F77I point mutation', The European journal of neuroscience, vol. 21, no. 11, pp. 3002-16. https://doi.org/10.1111/j.1460-9568.2005.04127.x

    Dateibeschreibung: application/pdf

  19. 19
  20. 20

    Quelle: Kogo, N, Dalezios, Y, Capogna, M, Ferraguti, F, Shigemoto, R & Somogyi, P 2004, 'Depression of GABAergic input to identified hippocampal neurons by group III metabotropic glutamate receptors in the rat', The European journal of neuroscience, vol. 19, no. 10, pp. 2727-40. https://doi.org/10.1111/j.0953-816X.2004.03394.x